Liquid Dosage

Therapeutical Proteins

Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.

Downloads

Insights da GEA

Kytero 10, as grandes mudanças começam pequenas

Com a kytero 10 da GEA, pesquisadores e desenvolvedores das indústrias de biofármacos, alimentícia e de novos alimentos agora contam com a mais recente geração de um poderoso acelerador à sua disposição.

Fueling the circular economy in shipping

Ports now compete not just on logistics, but on sustainability. At Greece’s Piraeus port, an advanced processing and recovery facility recycles ship waste oil into fuel. Equipped with GEA’s high-performance centrifuges, it sets a new benchmark for state-of-the-art, environmentally responsible port operations.

Scrambled egg made with egg altnerative

No cardápio: ovos mais sustentáveis

A GEA ajuda os clientes a testar e escalonar produtos e ingredientes alternativos ao ovo feitos com fermentação de precisão.

Receba notícias da GEA

Mantenha-se atualizado com as inovações e histórias da GEA, se registrando para receber notícias sobre a GEA.

Entre em contato

Estamos aqui para ajudar! Com apenas poucos detalhes poderemos responder à sua pergunta.